Citations
29
3.2 per year
Published
2016
Drug resistance mutations after first-line antiretroviral therapy failure in Rwanda
Antiviral Therapy•2016
Authors
JD Ndahimana, E Remera, JI Forrest, A Bukenya, A Binagwaho, EJ Mills, S Nsanzimana
Antiretroviral Therapy
Rwanda
Abstract
Background: Drug resistance is a major concern in HIV treatment programs. We characterized drug resistance mutations among patients who experienced first-line antiretroviral therapy failure in Rwanda to inform treatment switching strategies.
Related Publications
Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis
The Lancet HIV • 2017
The Lancet
HIV/AIDS
HIV care continuum in Rwanda: a cross-sectional analysis of the national programme
The Lancet HIV • 2015
The Lancet
HIV/AIDS
Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis
The Lancet HIV • 2016
The Lancet
HIV/AIDS